Matches 1 - 43 out of 43


Match Document Document Title
DE202011111124U1 Polymorph of a tretrasaccharide containing N-acetyllactosamine  
A polymorph of Galpβ1-4GlcNAcpβ1-3Galpβl-4Glc (LNnT), characterized in that it has X-ray powder diffraction reflections based on a measurement using CuKa radiation, at a 2Θ angle of 20.32 ± 0.20,...
DE202013012839U1 New polymorphs from LNnT  
A crystalline LNnT polymorph IV, characterized in that it shows X-ray powder diffraction reflections based on a measurement using CuKa radiation at 2Θ angles of 8.16 and 15.41, more preferably at...
DE202013012829U1 Improving the stability and purity and increasing the bioavailability of human milk oligosaccharides or precursors or mixtures thereof  
A spray-dried oligosaccharide from human milk (HMO) or a spray-dried HMO mixture with improved stability after prolonged storage at temperatures above 25 ° C and produced by a process comprising...
DE202013012827U1 Improving the stability and purity and increasing the bioavailability of human milk oligosaccharides or precursors or mixtures thereof  
Spray-dried neutral oligosaccharide from human milk (HMO) or a spray-dried neutral HMO mixture with improved stability after prolonged storage at temperatures above 25 ° C., which is produced by a...
DE202014011399U1 Neutral human milk oligosaccharides (HMOs) from microbial fermentation  
A concentrate of a neutral human milk oligosaccharide (HMO) product containing a desired HMO in a concentration of ≥ 100 g / l and one or more impurities in an aqueous solution, the HMO product...
DE102018000033A1 Process for accelerated general and skin regeneration and wound healing  
Method for accelerated wound healing and skin regeneration is characterized that quark or one or more of its ingredients with tomato or one or more of its ingredients be administered in combination.
DE102017110935A1 Anti-inflammatory high-purity oligosaccharides  
The present invention relates to a high-purity oligosaccharide for use as a pharmaceutical as well as to a pharmaceutical composition comprising the high-purity oligosaccharide of the present...
DE202018101105U1 Hygienic agent with active ingredient for lowering the pH of the vagina and / or the external genitals  
The hygienic agent (1) having an active substance for lowering the pH of the vagina and / or the external genitalia, where the active substance contains the crystalline lactic acid or its salts...
DE19861497B3 Babies' food and their use for the promotion of human colorectal flora  
According to the invention, baby food containing at least two different, soluble carbohydrates is provided. This baby food is characterized by the fact that the carbohydrates consist of a...
DE19861508A1 Carbohydrate mixture  
According to the invention, a carbohydrate mixture is provided for dietary diets and pharmaceuticals containing at least two different, soluble carbohydrates. This carbohydrate mixture is...
DE102012019029A1 Pharmaceutical formulation prepared by dissolving adjuvant in polyethylene glycols, useful for administration of active multiple charged anions e.g. heparin or its derivative, oligosaccharide or polysaccharide and nucleic acid sequence  
Oral pharmaceutical formulation prepared by dissolving an adjuvant in polyethylene glycols or their derivatives, is claimed.
DE19836339B4 carbohydrate blend  
Carbohydrate mixtures for dietetic foods and pharmaceuticals containing at least two different soluble carbohydrates, wherein the soluble carbohydrates consist of a carbohydrate component A...
DE102008020797A1 Skin cream useful for e.g. treatment and/or prophylaxis of dry skin and/or skin damage in diabetic foot, comprises saccharide e.g. mannobiose, polysaccharide e.g. dextran, multivalent alcohol e.g. glycerol, urea, polycation and carrier  
Skin cream comprises at least one saccharide, at least one polysaccharide, at least one multivalent alcohol, urea, at least one polycation and at least one pharmaceutically or cosmetically...
DE10226203B4 Condensed palatinose, processes for their preparation and their use  
process for producing condensed palatinose from palatinose by Melt, Palatinose a solution of a catalytically active acidic Substance added to water, the water in the obtained mixture is present in...
DE60118395T2 Pharmaceutical Compositions SUSTAINED RELEASE FOR PARENTERAL APPLICATION OF HYDROPHILIC SUBSTANCES  
Stable, biologically compatible pharmaceutical compositions in the form of water-in-oil microemulsions (w/o), for the sustained release by parenteral administration of active ingredients which are...
DE19961182B4 Galactomannan oligosaccharides and processes for their preparation and their use  
process for the production of mannose and galactose-containing oligosaccharides from galactomannans of guar gum, wherein an aqueous solution or suspension of guar gum prepared using a bacteria of...
DE102004025535A1 Combination of salts of o-acetylsalicylic acid and alpha-glucosidase inhibitors  
The Invention relates to a combination comprising a salt of o-acetylsalicylic acid with a basic amino acid as component A and an alpha-glucosidase inhibitor as component B, for the prevention of...
DE10262005B4 Food, beverages, sweeteners and pharmaceuticals, as well as compositions comprising condensed Palatinose in hydrogenated form  
vital or luxury food containing hydrogenated condensed Palatinose.
DE19829844B4 Use of D-galactose to prevent necrosis  
use of D-galactose and / or one or more D-galactose derivative / s - except hepatotoxic acting derivatives with galactosamine - prevention or reduction of necrosis or cell tissue damage.
DE10297369T5 Application of oligosaccharides in cosmetic or dermatological compositions for stimulating the adhesion of keratinocytes to the main proteins of the dermis-epidermis compound and for restoring the Epidermiskohäsion  
application of Oligogalakturonid in cosmetics or for the preparation of a dermatological composition as an agent for stimulating the Adhesion of basal keratinocytes at two major proteins of JDE,...
DE10262005A1 Foodstuff or pharmaceutical compositions containing hydrogenated condensed palatinose, useful e.g. as sweetener or soluble dietary fiber source and/or for combating intestinal inflammation or cancer  
Foodstuffs, sweeteners or pharmaceutical compositions containing hydrogenated condensed palatinose (I) are new. Foodstuffs, sweeteners or pharmaceutical compositions containing hydrogenated...
DE10219032A1 Oral hygiene products  
The invention relates to the use of sugar esters and sugar ethers to combat and avoid bad breath, and to methods and preparations for combating and preventing bad breath using or containing sugar...
DE10212502A1 Use of at least one flavonoid of quercetin to increase the level of useful short chain fatty acids (SCFA) in the lower intestinal tract  
The invention relates to the use of at least one flavonoid of quercetin in combination with at least one saccharide selected from resistant starch (RS), a non-starch polysaccharide or an...
DE10147156A1 Encapsulated carob fibers with improved product properties, processes for their production and their application  
The invention relates to fiber capsules, consisting of a core of essentially water-insoluble carob fiber and a capsule material made of at least one water-soluble fiber. The invention further...
DE10147100A1 Anti-infective carbohydrates  
The invention relates to the use of neutral straight-chain or branched oligosaccharides for preventing the invasion and infection of mammal cells by pathogens and for fighting diseases caused by...
DE10128110A1 Compounds for attachment to nucleic acids  
The invention relates to compounds of formula (I) wherein A respectively and independently from the other A group(s) represents a group comprising a ring of 5-6 ring atoms, said ring carrying at...
DE10117185A1 Composition, useful for treating diabetes mellitus, comprises vegetable dietary fiber and alpha-glucosidase inhibitor administered in combination or immediately before or after  
A composition (C) for treating diabetes mellitus, comprises vegetable dietary fiber(s) (I) and alpha -glucosidase inhibitor(s) (II). A composition (C) for treating diabetes mellitus, comprises...
DE10137459A1 Agent, useful for the treatment of diabetes mellitus, comprises a combination of cellulose and an alpha-glucosidase inhibitor  
An agent (I) for the treatment of diabetes mellitus, comprises a combination of cellulose and at least one alpha-glucosidase inhibitor.
DE10110124A1 Composition for treating diabetes mellitus, especially of type II, comprising vegetable dietary fiber or cellulose and alpha-glucosidase inhibitor  
A composition (A) for treating diabetes mellitus contains: (a) at least one type of vegetable dietary fiber and at least one alpha -glucosidase inhibitor (AGI); (b) cellulose and at least one AGI;...
DE10104055A1 Use of carbohydrates for the removal of intestinal infections in animals  
The invention relates to a the use of carbohydrates, especially 1-O- alpha -D-glucopyranosyl-D-sorbitol, 6-O- alpha -D-glucopyranosyl-sorbitol, lactobionic acid, maltobionic acid, condensed...
DE10063433A1 Use of DNA repair enzymes as MMP-1 inhibitors  
The invention relates to the use of photolyase enzymes and T4 endonuclease V as substances that inhibit MMP-1 in cosmetic or pharmaceutical preparations, for preventing the light-induced ageing of...
DE10028204A1 Method for identifying medically useful agents  
The invention relates to a method for identifying inhibitors or ligands for binding domains. The inventive method comprises using a protein that has at least one catalytic domain, incubating it...
DE19961182A1 Galactomannan oligosaccharides and processes for their preparation and their use  
The invention relates to methods for the hydrolysis of galactomannan compounds and various uses of the hydrolysate.
DE19958985A1 oligosaccharide  
The invention relates to an oligosaccharide mixture based on oligosaccharides produced from one or several animal milks and which are composed of two or more monosaccharide units. Said...
DE19860698A1 New pharmaceutical composition  
The invention relates to a pharmaceutical composition with improved effect and tolerability for the treatment of type II diabetes mellitus. Said composition contains a combination of metformin...
DE19836339A1 Carbohydrate mixture comprising oligosaccharide and polysaccharide components with prebiotic properties useful as nutritional supplement or as pharmaceutical  
A carbohydrate mixture comprising one or more soluble oligosaccharides and one or more soluble polysaccharides, with at least 80 wt. % of each being prebiotic, i.e. not digested and not resorbed...
DE19829844A1 Use of D-galactose to prevent necrosis  
The invention relates to the use of D-galactose and / or a D-galactose derivative for the prevention or reduction of necrosis or cell or tissue damage.
DE19818842C1 Cold remedy containing sugar alcohol mixture such as Isomalt, having immunostimulant and antimicrobial activity  
The use of a sugar alcohol mixture (I) containing 6-O- alpha -glucopyranosyl-D-sorbitol (GPS) and 1-O- alpha -D-glucopyranosyl-D-mannitol (GPM) is claimed as active agent in foodstuff, medicament...
DE19709897A1 Bismuth salts of antibiotics of the moenomycin group, processes for their preparation, their use and pharmaceutical compositions containing such salts  
The present invention relates to bismuth salts of antibiotics of the moenomycin group, to processes for their preparation, to their use and to medicaments containing such salts. The salts...
DE19640791A1 Glycoconjugates as inhibitors of viral cell adhesion  
The host-cell adhesion by human influenza viruses is inhibited by new compounds of the general formula (1), where R<1> stands for acyl or a thioacyl group; R<2> for hydroxyl, Z-alkyl, substituted...
DE4137236A1 OLIGOSACCHARIDE WITH ANTIGENS DETERMINANTS FROM SCHLEIMHUELLE OF AMPHIBIANS EGGS  
The invention relates to novel fucosylated oligosaccharides, those in considerable quantities from the mucus envelope of egg yolks of amphibians, preferably the family der Molche, can be isolated...
DE4123714A1 Recovering oligo:saccharide(s) from cereal plants  
Grass seeds are germinated and grown under special condmitions, and the plants macerated and extracted by aq. treatment at different temp. and pH conditions. The crude extract is purified by...
DE3807594A1 ANTIKOERPER, PROCESS FOR PRODUCING, OLIGOSACCHARIDE-haptens and CLONES FOR PRODUCING THE ANTIKOERPER AND USE OF ANTIKOERPER FOR THE DIAGNOSIS AND TREATMENT OF TUMORS  
Antibodies, specific for N-glycane structures of cell membrane surfaces and which, in an immunoassay, for example RIA and ELISA assay, or microtiter plates, exhibit a positive reaction to antigen...

Matches 1 - 43 out of 43